Dolby Laboratories (DLB) Tops Q4 EPS by 10c, Offers Q1 & FY16 Outlook

Go back to Dolby Laboratories (DLB) Tops Q4 EPS by 10c, Offers Q1 & FY16 Outlook

Dolby Laboratories (DLB) Reports 4Q EPS Miss; B. Riley Cuts Price target to $41

October 22, 2015 9:31 AM EDT

B. Riley maintained a Neutral rating on Dolby Laboratories (NYSE: DLB), and cut the price target to $41.00 (from $42.50), following the company's 4Q15 earnings results. Revenues of $229.5MM missed consensus of $235.8MM, and the low-end of the $230-240MM guidance. EPS came in at $0.27 compared to... More